Page 362 - fbkCardioDiabetes_2017

Role of Nuclear Imaging in The Evaluvation of Non Coronary
338
Artery Disease

Conclusion 7. Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine- 123 me-
ta-iodobenzylguanidine imaging and cardiac events in heart failure. Re-
Nuclear imaging in patients with non-coronary ar- sults of the prospective ADMIRE-HF (AdreView myocardial imaging for risk
tery disease plays a important role in diagnosis of evaluation in heart failure) study. J Am Coll Cardiol. 2010;55:2212–21.
different disease, predicting prognosis in patients 8. Goldberg AS, Alraies MC, Cerqueira MD, et al. Prognostic value of
with heart failure and guiding therapeutic options to left ventricular mechanical dyssynchrony by phase analysis in patients
the cardiologists. With the advent of new radiotracer with non-ischemic cardiomyopathy with ejection fraction 35-50% and
in this field role of nuclear imaging in patients with QRS<150 ms. J Nucl Cardiol 2014;21:57-66.
non-coronary artery disease will further progress. 9. Harinstein ME, Soman P. Radionuclide Imaging Applications in Cardiomy-
opathies and Heart Failure. Curr Cardiol Rep. 2016;18(3):23.
Important points:
10. Schwartz RG, McKenzie WB, Alexander J, et al: Congestive heart failure
Gated myocardial perfusion SPECT (GMPS) helps and left ventricular dysfunction complicating doxorubicin therapy seven-
in differentiating ischemic cardiomyopathy from year experience using serial radionuclide angiocardiography. Am JMed
1987;82:1109-18.
non-ischemic cardiomyopathy.
11. Mitra D, Basu S. Equilibrium radionuclide angiocardiography: Its usefulness
Equilibrium radionuclide angiography (ERNA) helps in current practice and potential future applications. World J Radiol 2012;
to accurately evaluate left ventricular ejection fraction 4 (10): 421-30
(LVEF) and thereby determine the treatment modality 12. Kircher M, Lapa C. Novel Noninvasive Nuclear Medicine Imaging Techniques
in heart failure patients. for Cardiac Inflammation. Curr Cardiovasc Imaging Rep. 2017;10(2):6.
Phase analysis of ERNA and GMPS are helpful in
predicting response to Cardiac resynchronisation
therapy (CRT).

Cardiac autonomic innervations imaging with 123-Io-
dine MIBG is helpful in risk stratification and prog-
nostication in patients with heart failure.
ERNA has been extensively used to monitor chemo-
therapy induced caardiotoxicity.
FDG PET-CT has been used extensively for myocar-
dial infection and inflammation imaging.

References
1. YancyCW, JessupM, Bozkurt B, et al. 2013 ACCF/AHA guideline for the
management of heart failure: a report of the American college of cardiology
foundation/american heart association task force on practice guidelines.
Circulation. 2013;128:e240–327.
2. Frais M, Botvinick E, Shosa D, et al. Phase image characterization of
localized and generalized left ventricular contraction abnormalities. J Am
Coll Cardiol. 1984; 4:987–98.
3. Mukherjee A, Patel CD, Naik N,.et al. Quantitative assessment of cardiac
mechanical dyssynchrony and prediction of response to cardiac resynchro-
nization therapy in patients with non-ischaemic dilated cardiomyopathy
using equilibrium radionuclide angiography. Europace. 2016; 18:851-7.
4. Chen J, Garcia EV, Folks RD, et al. Onset of left ventricular mechanical
contraction as determined by phase analysis of ECG gated myocardial
perfusion SPECT imaging: Development of a SPECT myocardial perfusion
imaging diagnostic tool for assessment of cardiac mechanical dyssynchrony.
J Nucl Cardiol 2005; 12:687-95.
5. Mukherjee A, Patel CD, Naik N, et al. Quantitative assessment of cardiac
mechanical dyssynchrony and prediction of response to cardiac resynchro-
nization therapy in patients with nonischaemic dilated cardiomyopathy
using gated myocardial perfusion SPECT. Nucl Med Commun. 2015;
36:494-501.
6. Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ. Altered expression
of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the
failing human heart. Circulation. 1993;87:454–63.

GCDC 2017